Register
Login:
Share:
Email Facebook Twitter


Exclusive: Hardman & Co call the lithium market: is a change in trend happening?
Tower Resources identify 18 million barrels of contingent reserves worth $118M in Cameroon


Regulatory News


Posting of Annual Report and Notice of AGM

Thu, 11th Oct 2018 10:50


RNS Number : 7500D
Craneware plc
11 October 2018

11 October 2018

Craneware plc

("Craneware" or the "Company")

Posting of Annual Report and Notice of AGM

The Company's 2018 Annual Report has been posted to shareholders together with the Notice of Annual General Meeting and the associated form of proxy. The Company's AGM will be held at the offices of Peel Hunt LLP, 120 London Wall, London, EC2Y 5ET, UK, on 6 November 2018 at 1pm.

Among the resolutions will be the declaration of a final dividend for the year ended 30 June 2018 of 14.0 pence per share giving a total dividend for the year of 24.0 pence per share. The final dividend will be paid on 6 December 2018 to shareholders on the register as at 9 November 2018, with a corresponding ex-Dividend date of 8 November 2018.

The final dividend of 14.0 pence per share is capable of being paid in US dollars subject to a shareholder having registered to receive their dividend in US dollars under the Company's Dividend Currency Election, or who register to do so by the close of business on 9 November 2018. The exact amount to be paid will be calculated by reference to the exchange rate to be announced on 9 November 2018.

The Annual Report, the Notice of AGM and related documents are available on the Company's website at www.craneware.com

For further information, please contact:

Craneware plc

Peel Hunt (NOMAD & Joint Broker)

Investec Bank (Joint Broker)

Alma (Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)208 004 4217

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Guy Pengelley

Sebastian Lawrence

Henry Reast

Robyn Fisher

Josh Royston





About Craneware

Craneware enables healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
NOAKFLBFVBFZFBZ


Related Shares:
Craneware (CRW)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.